This observation suggested that brain metastases originating from lung cancer might have a more favorable outcome after immunotherapy than those from breast or colorectal cancer, due to higher expression of genes belonging to the PD‐1/PD‐L1 axis, tumor‐infiltrating markers, and interferon signatures. This evidence concerns the gene CD274 and neoplasm.